|
1
|
Karim S, Mirza Z, Naseer MI, Al-Qahtani MH
and Ali A: Clinicopathological characteristics and chronology of
p53 expression in the development of gastric cancer.
Hepatogastroenterology. 60:2113–2118. 2013.PubMed/NCBI
|
|
2
|
Krejs GJ: Gastric cancer: Epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dhobi MA, Wani KA, Parray FQ, Wani RA,
Wani ML, Peer GQ, Abdullah S, Wani IA, Wani MA, Shah MA, et al:
Gastric cancer in young patients. Int J Surg Oncol.
2013:9816542013.PubMed/NCBI
|
|
4
|
Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ
and Kim SK: Clinicopathologic characteristics of gastric carcinoma
in elderly patients: A comparison with young patients. World J
Gastroenterol. 11:22–26. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hsieh FJ, Wang YC, Hsu JT, Liu KH, Yeh CN,
Yeh T-S, Hwang T-L and Jan Y-Y: Clinicopathological features and
prognostic factors of gastric cancer patients aged 40 years or
younger. J Surg Oncol. 105:304–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park HJ, Ahn JY, Jung HY, Lim H, Lee JH,
Choi KS, Kim DH, Choi KD, Song HJ, Lee GH, et al: Clinical
characteristics and outcomes for gastric cancer patients aged 18–30
years. Gastric Cancer. 17:649–660. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kashiwagi Y, Kato N, Sassa T, Nishitsuka
K, Yamamoto T, Takamura H and Yamashita H: Cotylenin A inhibits
cell proliferation and induces apoptosis and PAX6 mRNA transcripts
in retinoblastoma cell lines. Mol Vis. 16:970–982. 2010.PubMed/NCBI
|
|
8
|
Tchernitsa O, Kasajima A, Schäfer R, Kuban
RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert
MP, et al: Systematic evaluation of the miRNA-ome and its
downstream effects on mRNA expression identifies gastric cancer
progression. J Pathol. 222:310–319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Xu L and Jiang L: miR-1271
promotes non-small-cell lung cancer cell proliferation and invasion
via targeting HOXA5. Biochem Biophys Res Commun. 458:714–719. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naugler WE and Karin M: The wolf in
sheep's clothing: The role of interleukin-6 in immunity,
inflammation and cancer. Trends Mol Med. 14:109–119. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ashizawa T, Okada R, Suzuki Y, Takagi M,
Yamazaki T, Sumi T and Aoki T, Ohnuma S and Aoki T: Clinical
significance of interleukin-6 (IL-6) in the spread of gastric
cancer: Role of IL-6 as a prognostic factor. Gastric Cancer.
8:124–131. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dey AB: World report on ageing and health.
Indian J Med Res. 145:150–151. 2017. View Article : Google Scholar
|
|
13
|
Sasaki M, Ikeda H, Sato Y and Nakanuma Y:
Proinflammatory cytokine-induced cellular senescence of biliary
epithelial cells is mediated via oxidative stress and activation of
ATM pathway: A culture study. Free Radic Res. 42:625–632. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartek J, Hodny Z and Lukas J: Cytokine
loops driving senescence. Nat Cell Biol. 10:887–889. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akbaraly TN, Hamer M, Ferrie JE, Lowe G,
Batty GD, Hagger-Johnson G, Singh-Manoux A, Shipley MJ and Kivimäki
M: Chronic inflammation as a determinant of future aging
phenotypes. CMAJ. 185:E763–E770. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gorelick PB: Role of inflammation in
cognitive impairment: Results of observational epidemiological
studies and clinical trials. Ann NY Acad Sci. 1207:155–162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Satizabal CL, Zhu YC, Mazoyer B, Dufouil C
and Tzourio C: Circulating IL-6 and CRP are associated with MRI
findings in the elderly: The 3C-Dijon Study. Neurology. 78:720–727.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guggenheim DE and Shah MA: Gastric cancer
epidemiology and risk factors. J Surg Oncol. 107:230–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Paoletti X, Oba K, Burzykowski T, Michiels
S, Ohashi Y, Pignon JP, Rougier P, Sakamoto J, Sargent D, Sasako M,
et al GASTRIC (Global Advanced/Adjuvant Stomach Tumor Research
International Collaboration) Group, : Benefit of adjuvant
chemotherapy for resectable gastric cancer: A meta-analysis. JAMA.
303:1729–1737. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Skinnider BF and Mak TW: The role of
cytokines in classical Hodgkin lymphoma. Blood. 99:4283–4297. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nurul-Syakima AM, Yoke-Kqueen C, Sabariah
AR, Shiran MS, Singh A and Learn-Han L: Differential microRNA
expression and identification of putative miRNA targets and
pathways in head and neck cancers. Int J Mol Med. 28:327–336.
2011.PubMed/NCBI
|
|
23
|
Maurel M, Jalvy S, Ladeiro Y, Combe C,
Vachet L, Sagliocco F, Bioulac-Sage P, Pitard V, Jacquemin-Sablon
H, Zucman-Rossi J, et al: A functional screening identifies five
microRNAs controlling glypican-3: Role of miR-1271 down-regulation
in hepatocellular carcinoma. Hepatology. 57:195–204. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang XJ, Deng J, Liu YW, Wan LY, Feng M,
Chen J and Xiong JP: MiR-1271 inhibits cell proliferation, invasion
and EMT in gastric cancer by targeting FOXQ1. Cell Physiol Biochem.
36:1382–1394. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Judd LM, Alderman BM, Howlett M, Shulkes
A, Dow C, Moverley J, Grail D, Jenkins BJ, Ernst M and Giraud AS:
Gastric cancer development in mice lacking the SHP2 binding site on
the IL-6 family co-receptor gp130. Gastroenterology. 126:196–207.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sampaio AM, Balseiro SC, Silva MR, Alarcão
A, d'Aguiar MJ, Ferreira T and Carvalho L: Association between IL-4
and IL-6 expression variants and gastric cancer among Portuguese
population. GE Port J Gastroenterol. 22:143–152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ohi S, Hashimoto H, Tachibana T, Tabei I,
Nakajima M, Sato K, Yanaga K and Ishikawa H: Establishment and
characterization of EB virus-free normal B-lymphocyte and
interleukin-6-producing poorly differentiated adenocarcinoma cell
lines derived from gastric tumor tissue. Hum Cell. 18:35–44. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang SP, Wu MS, Wang HP, Yang CS, Kuo ML
and Lin JT: Correlation between serum levels of interleukin-6 and
vascular endothelial growth factor in gastric carcinoma. J
Gastroenterol Hepatol. 17:1165–1169. 2002. View Article : Google Scholar : PubMed/NCBI
|
